T1-Weighted Dynamic Contrast-Enhanced MRI Is a Noninvasive Marker of Epidermal Growth Factor Receptor vIII Status in Cancer Stem Cell-Derived Experimental Glioblastomas
Politi, Letterio S. Brugnara, G. Castellano, A. Cadioli, M. Altabella, L. Peviani, M. Mazzoleni, S. Falini, A. Galli, R.
Politi, Letterio S.
Brugnara, G.
Castellano, A.
Cadioli, M.
Altabella, L.
Peviani, M.
Mazzoleni, S.
Falini, A.
Galli, R.
Citations
Altmetric:
Student Authors
Faculty Advisor
Academic Program
UMass Chan Affiliations
Document Type
Response or Comment
Publication Date
2016-06-01
Subject Area
Collections
Embargo Expiration Date
Link to Full Text
Abstract
We read with great interest the article by Arevalo-Perez et al, describing the potential value of T1-weighted dynamic contrast-enhanced MR imaging (DCE-MR imaging) as a biomarker for epidermal growth factor receptor variant III (EGFRvIII) mutation in patients with glioblastoma (GBM).
Source
AJNR Am J Neuroradiol. 2016 Jun;37(6):E49-51. Mar 17. Link to article on publisher's site
Year of Medical School at Time of Visit
Sponsors
Dates of Travel
DOI
10.3174/ajnr.A4774
Permanent Link to this Item
PubMed ID
26988813